|
SP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36699548850083E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34290381434721E-11 |
| Normal-vs-Stage2 |
1.13420000003028E-06 |
| Normal-vs-Stage3 |
2.81980000016446E-07 |
| Normal-vs-Stage4 |
6.57449999996729E-08 |
| Stage1-vs-Stage2 |
8.267400E-01 |
| Stage1-vs-Stage3 |
9.823800E-01 |
| Stage1-vs-Stage4 |
2.297200E-01 |
| Stage2-vs-Stage3 |
8.015800E-01 |
| Stage2-vs-Stage4 |
1.178370E-01 |
| Stage3-vs-Stage4 |
1.841360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17680309941193E-11 |
| Normal-vs-AfricanAmerican |
1.88539994727677E-09 |
| Normal-vs-Asian |
1.91149999995144E-06 |
| Caucasian-vs-AfricanAmerican |
8.037400E-01 |
| Caucasian-vs-Asian |
3.638400E-01 |
| AfricanAmerican-vs-Asian |
2.512600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77189382558163E-12 |
| Normal-vs-Female |
2.15869999999896E-05 |
| Male-vs-Female |
8.804400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.54310000005853E-07 |
| Normal-vs-Extreme_Weight |
1.80500059343558E-11 |
| Normal-vs-Obese |
7.08749947619935E-10 |
| Normal-vs-Extreme_Obese |
3.51670000009463E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.998800E-01 |
| Normal_Weight-vs-Obese |
8.939600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.404600E-01 |
| Extreme_Weight-vs-Obese |
3.121600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.824800E-01 |
| Obese-vs-Extreme_Obese |
2.779800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.37469999999629E-05 |
| Normal-vs-Age(41-60Yrs) |
3.80020004353554E-09 |
| Normal-vs-Age(61-80Yrs) |
1.62914126633495E-12 |
| Normal-vs-Age(81-100Yrs) |
4.25059999975552E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.942800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.596390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.092400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.647800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.622600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72859948577297E-10 |
| Normal-VS-Type2 PRCC |
1.64650515444009E-11 |
| Normal-VS-KIRP CIMP |
4.40080000000398E-05 |
| Normal-VS-Unclassified PRCC |
2.52560000002511E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.344800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.941400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.956400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.643600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.773000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.821400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7274959240865E-11 |
| Normal-vs-N1 |
3.49260000032103E-07 |
| Normal-vs-N2 |
9.585500E-04 |
| N0-vs-N1 |
4.240600E-01 |
| N0-vs-N2 |
9.631800E-01 |
| N1-vs-N2 |
7.029400E-01 |
|
|
